Apyx Medical Corp (APYX) › Cash & EquivalentsApyx Medical Corp (APYX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $2.56M2009: $2.15M2010: $3.83M2011: $4.88M2012: $4.16M2013: $7.92M2014: $5.73M2015: $11.80M2016: $14.46M2017: $9.95M2018: $16.60M2019: $58.81M2020: $41.91M2021: $30.87M2022: $10.19M2023: $43.65M2024: $31.74M2025: $31.74M$31.74M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$31.74M-0.0%2024$31.74M-27.3%2023$43.65M+328.3%2022$10.19M-67.0%2021$30.87M-26.4%2020$41.91M-28.7%2019$58.81M+254.4%2018$16.60M+66.8%2017$9.95M-31.2%2016$14.46M+22.5%2015$11.80M+105.9%2014$5.73M-27.7%2013$7.92M+90.4%2012$4.16M-14.7%2011$4.88M+27.5%2010$3.83M+77.6%2009$2.15M-16.0%2008$2.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share